| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | 0.0081 | 0.9 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.9 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |